Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Glucotrack, Inc. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 2.74M | $85.1M | $31.00 | Mar 12, 2025 | John A. Ballantyne Rev Trust 08/01/2017 |
Glucotrack, Inc. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 4.13K | $128K | $31.00 | Mar 26, 2025 | Direct |
Glucotrack, Inc. | Director, 10%+ Owner | Series A Common Warrant | 132K | Nov 14, 2024 | John A. Ballantyne Rev Trust 08/01/2017 | ||
Glucotrack, Inc. | Director, 10%+ Owner | Warrants to Purchase Common Stock | 59.3K | Jul 30, 2024 | John A. Ballantyne Rev Trust 08/01/2017 | ||
Glucotrack, Inc. | Director, 10%+ Owner | Series B Common Warrant | 0 | Mar 12, 2025 | John A. Ballantyne Rev Trust 08/01/2017 |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GCTK | Glucotrack, Inc. | Aug 16, 2024 | 0 | $0 | 3 | Nov 22, 2024 | Director, 10%+ Owner |
GCTK | Glucotrack, Inc. | Jul 30, 2024 | 9 | $4.09M | 4 | Mar 31, 2025 | Director, 10%+ Owner |